1,2,3,4-tetrahydropyrazin-2-yl acetamides and methods of use

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S217050, C514S255050, C544S405000

Reexamination Certificate

active

07662811

ABSTRACT:
Selected compounds are effective for treatment of pain and diseases, such as inflammation mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving pain, inflammation, and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

REFERENCES:
patent: 2005/0014749 (2005-01-01), Chen et al.
patent: WO 03/007958 (2003-01-01), None
patent: WO 03/093245 (2003-11-01), None
patent: WO 2004/033436 (2004-04-01), None
patent: 2004/054854 (2004-07-01), None
patent: 2004/083173 (2004-09-01), None
patent: WO 2005/061467 (2005-07-01), None
Dorwald F. A. Side Reactions in Organic Synthesis, 2005, Wiley: VCH, Weinheim p. IX of Preface.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

1,2,3,4-tetrahydropyrazin-2-yl acetamides and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 1,2,3,4-tetrahydropyrazin-2-yl acetamides and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,2,3,4-tetrahydropyrazin-2-yl acetamides and methods of use will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4165095

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.